GSK126 played a vital role in promoting IFN-γ, which increased CXCL9 and CXCL10 expression in the tumor, promoting T cell proliferation, maturation, activation, and chemotaxis into GBM, thereby inhibiting tumor growth and prolonging survival. This evidence concerns the gene IFNG and glioblastoma.